Corpus ID: 36394566

[A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].

@article{Wada1987ACC,
  title={[A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].},
  author={T. Wada and T. Nishide and K. Hatayama and S. Chang and M. Tatsuta and M. Yasutomi},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={1987},
  volume={14 8},
  pages={
          2509-12
        }
}
  • T. Wada, T. Nishide, +3 authors M. Yasutomi
  • Published 1987
  • Medicine
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • In order to evaluate the clinical efficacy of combined tegafur plus lentinan treatment, a comparative trial was performed on patients with advanced cancer using two different doses, a conventional-dose group and a high-dose group. Thirty-four patients were evaluable in this trial. The doses of medication were 600 mg of tegafur p.o. daily and 1-2 mg of lentinan i.v. weekly in the conventional-dose group, and 1,200-800 mg of tegafur p.o. daily and 4 mg of lentinan i.v. weekly in the high-dose… CONTINUE READING
    6 Citations
    Beta-glucan contamination of pharmaceutical products: How much should we accept?
    • 19
    • PDF
    BY DIETARY MUSHROOM COMPOUNDS
    • PDF